The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,023,802 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Southcentral Foundation, an Alaska Native non-profit healthcare organization. The 5-year grant aims to reduce unmet treatment needs and opioid overdose-related deaths in the Matanuska-Susitna Borough and northern Anchorage, Alaska through the provision of culturally...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $750,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Kawerak, Inc., a non-profit tribal consortium in Nome, Alaska. The grant funding will support the Bering Strait Opioid Response Initiative, a comprehensive project aimed at transforming substance use prevention, harm reduction, treatment, and recovery services for Alaska...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,000,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Village of Alakanuk in Alaska. The grant will fund the Alakanuk Tribal Opioid Response Program over a 5-year period from September 2024 to September 2029. The program will implement culturally informed community and school-based opioid prevention education...
The State of Alaska Department of Health (DOH) was awarded a $23,966,144 Project Grant under the Substance Abuse and Mental Health Services Administration's (SAMHSA) Opioid State Targeted Response (Opioid STR) program (CFDA 93.788). The grant will fund a comprehensive approach to address the opioid crisis in Alaska through prevention, harm reduction, treatment, and recovery services over a project period from September 30, 2024 to September 29, 2027. Key initiatives include sustaining the...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $749,994 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Mount Sanford Tribal Consortium (MSTC) in Alaska. The 5-year grant, which commenced on September 30, 2024, aims to address high rates of drug abuse and suicide in rural Alaska communities through culturally-sensitive outreach and youth healing activities. Key program...
The Kenaitze Indian Tribe was awarded a $998,524 project grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The 5-year grant, which runs from September 30, 2024 to September 29, 2029, will enhance the availability of medication-assisted treatment (MAT) case management services to support at least 75 Alaska Native/American Indian clients...
The Akiachak Native Community was awarded a $1,250,000 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. This 5-year grant will fund culturally informed and responsive community and school-based opioid prevention education activities to raise awareness about the dangers of opioid use. The program will teach community members and youth to...
The Yukon-Kuskokwim Health Corporation (YKHC) was awarded a $1,499,998 Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) grant from the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA). The 5-year project, titled the Tribal Opioid Response (TOR) program, will provide residential and outpatient opioid treatment services as well as community outreach and education to address the...
The Akiak Native Community received a $749,997 Substance Abuse and Mental Health Services Project Grant (CFDA 93.243) from the Substance Abuse and Mental Health Services Administration (SAMHSA) to implement the Akiak Tribal Opioid Response Project. The project aims to provide culturally-informed opioid prevention education, harm reduction services, and comprehensive support for individuals with opioid use disorders in the Akiak, Alaska community. Key activities include implementing...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $5,523,249 Block Grant for Prevention and Treatment of Substance Abuse (CFDA 93.959) to the State of Alaska Department of Health. This two-year grant, effective from October 1, 2024 to September 30, 2026, will support comprehensive substance abuse prevention, treatment, and rehabilitation activities across the state. The grant enables the State of Alaska Department of Health to deliver a wide range of interventions,...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,005,154 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Southeast Alaska Regional Health Consortium (SEARHC). This 5-year grant (9/30/2024 - 9/29/2029) will enable SEARHC to expand evidence-based opioid use disorder treatment services at its clinics in Juneau, Alaska and establish a new opioid treatment program site in Ketchikan, Alaska.
SEARHC's program will utilize medication-assisted treatment (MAT) approaches, including buprenorphine and methadone, combined with behavioral therapies and recovery support services. It will also leverage a virtual dosing program to enable remote patient monitoring and increase access to treatment. Additionally, the program will incorporate traditional Alaska Native cultural practices and knowledge into its substance abuse treatment and recovery services. This comprehensive effort aims to address the opioid overdose crisis within tribal communities by expanding access to effective, culturally-responsive substance use disorder treatment and recovery support.